Automated multimodal severity assessment of diabetic retinopathy using ultra-widefield color fundus photography and clinical tabular data
Biomedical Signal Processing and Control · 2026-02 · 112 · 108673
DOI: 10.1016/j.bspc.2025.108673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Signal Processing and Control, 2026-02. Verfasst von Alireza Rezaei und 13 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Research Agency.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- French National Research Agency
Zitieren
APA
Rezaei, A., Matta, S., Zeghlache, R., Conze, P., Lepicard, C., Deman, P., Borderie, L., Cosette, D., Bonnin, S., Couturier, A., Cochener, B., Lamard, M., Daho, M. E. H., & Quellec, G. (2026). Automated multimodal severity assessment of diabetic retinopathy using ultra-widefield color fundus photography and clinical tabular data. Biomedical Signal Processing and Control, 112, 108673. https://doi.org/10.1016/j.bspc.2025.108673
Vancouver
Rezaei A, Matta S, Zeghlache R, Conze P, Lepicard C, Deman P, et al. Automated multimodal severity assessment of diabetic retinopathy using ultra-widefield color fundus photography and clinical tabular data. Biomedical Signal Processing and Control. 2026;112:108673. doi:10.1016/j.bspc.2025.108673
BibTeX
@article{Rezaei2026,
author = {Rezaei, Alireza and Matta, Sarah and Zeghlache, Rachid and Conze, Pierre-Henri and Lepicard, Capucine and Deman, Pierre and Borderie, Laurent and Cosette, Deborah and Bonnin, Sophie and Couturier, Aude and Cochener, Béatrice and Lamard, Mathieu and Daho, Mostafa El Habib and Quellec, Gwenolé},
title = {Automated multimodal severity assessment of diabetic retinopathy using ultra-widefield color fundus photography and clinical tabular data},
journal = {Biomedical Signal Processing and Control},
year = {2026},
volume = {112},
pages = {108673},
doi = {10.1016/j.bspc.2025.108673}
}
EUVIMED